GLP-1 drugs like Ozempic and Wegovy have transformed conversations around weight loss and metabolic health — but are we witnessing a medical breakthrough or participating in a massive social experiment?In this episode, we explore how these FDA-approved drugs moved from diabetes treatment to mainstream use for weight management, reshaping medicine, ethics, and culture along the way. We discuss how science identifies new uses for existing drugs, what we’ve learned from past off-label revolutions, and why GLP-1s may be testing not just our metabolism, but our trust in modern medicine itself.Topics include:How GLP-1 receptor agonists work in the brain and bodyWhy appetite, reward, and dopamine matterThe balance between scientific discovery and real-world experimentationWhat this moment reveals about how we use (and market) medicine todayAvailable on all streaming platforms — just search “Gopu & Zane” or visit lybrandlab.org/jospod

Ver todos los episodios